Psychological treatment for patients with chronic kidney disease
Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease
This study is testing whether Acceptance and Commitment Therapy can help improve the mental well-being of people with chronic kidney disease who are on hemodialysis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 104 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universidad Europea de Madrid Academic / other |
| Locations | 1 site (Madrid) |
| Trial ID | NCT06109493 on ClinicalTrials.gov |
What this trial studies
This study investigates the efficacy of Acceptance and Commitment Therapy (ACT) as a psychological intervention for patients suffering from chronic kidney disease. Participants will be assessed for eligibility and then randomly assigned to either a control group or an intervention group receiving 8 sessions of ACT. The effectiveness of the treatment will be evaluated using self-report instruments before and after the intervention, as well as at a 3-month follow-up. The study aims to provide insights into the psychological well-being of patients undergoing hemodialysis.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old with chronic kidney disease on hemodialysis for at least 3 months and experiencing moderate to severe depression.
Not a fit: Patients with severe mental disorders, cognitive impairments, or those currently receiving other psychological treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the mental health and quality of life for patients with chronic kidney disease.
How similar studies have performed: While the use of ACT in chronic illness management is gaining attention, this specific application in chronic kidney disease is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with chronic kidney disease on haemodialysis * Older than 18 years-old * At least 3 months on haemodialysis * HADS Global Scale Score ≥14 Exclusion Criteria: * Diagnosis of severe or chronic mental disorder, mental retardation and cognitive impairment, or disabling illness. * Antidepressant drugs consume * Insufficient understanding of Spanish. * Patients who are in the Advanced Chronic Kidney Disease Unit * Receiving other psychological treatment
Where this trial is running
Madrid
- Fundación Renal Iñigo Alvarez de Toledo — Madrid, Spain (Recruiting)
Study contacts
- Principal investigator: Francisco Montesinos, Ph.D. — Universidad Europea de Madrid
- Study coordinator: Francisco Montesinos, Ph.D.
- Email: francisco.montesinos@universidadeuropea.es
- Phone: +34647413773
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.